期刊文献+

NGAL在胰腺癌组织中的表达研究 被引量:1

Expression of NGAL in Pancreatic Cancer Tissues
原文传递
导出
摘要 目的探讨中性粒细胞明胶酶相关脂质运载蛋白(NGAL)在裸鼠原位胰腺癌组织中的表达情况以及与胰腺癌发生发展的关系。方法应用RT-PCR法检测22例裸鼠胰腺癌模型癌组织、癌旁组织和正常胰腺组织中NGAL基因及其编码蛋白的表达情况;采用免疫组化方法检测22例胰腺癌组织石蜡切片中NGAL蛋白表达情况。结果胰腺癌组织及其癌旁组织中NGAL m RNA相对表达量明显高于正常胰腺组织(P<0.05),胰腺癌组织中NGAL m RNA相对表达量又明显高于癌旁组织(P<0.05);NGAL蛋白在胰腺癌组织中的表达强阳性率以及相对表达量均明显高于癌旁组织和正常胰腺组织(P<0.05)。结论 NGAL在胰腺癌组织中呈高表达,NGAL可能是胰腺癌发生发展过程中的重要调节因子。 Objetive To study the expression of lipid associated with neutrophil gelatinase associated lipocalin (NGAL) in nude mice orthotopic pancreatic cancer tissues and the relationship between the occurred and development of pancreatic cancer. Methods The expressions of NGAL mRNA and protein of pancreatic cancer tissues and their adjacent tissues, and normal pancreatic tissues in nude mice were detected by using RT-PCR and immunohistochemical methods. Results The expressions of NGAL mRNA in pancreatic cancer tissues and adjacent tissues were significantly higher than that in normal pancreatic tissues (P〈0.05), and the expression of NGAL mRNA in pancreatic carcinoma tissues was significantly higher than that in para carcinoma tissues (P〈0.05). The strong positive expression rate of NGAL protein in pancreatic carcinoma tissues was significantly higher than thoes in para carcinoma tissues and normal pancreatic tissues (P〈0.05). Conclusions NGAL is highly expressed in pancreatic cancer tissues, and NGAL may be an important regtdatory factor in the development of pancreatic cancer.
出处 《中国普外基础与临床杂志》 CAS 2016年第1期33-37,共5页 Chinese Journal of Bases and Clinics In General Surgery
基金 惠州市科学计划项目(项目编号:2012Y136)~~
关键词 胰腺癌 中性粒细胞明胶酶相关脂质运载蛋白 基因表达 蛋白表达 裸鼠 Pancreatic cancer Neutrophil gelatinase associated lipocalin Gene expression Pprotein expression Nude mice
  • 相关文献

参考文献26

  • 1Dong M, Dong Q, Zhang H, et al. Expression of Gadd45a and p53 proteins in human pancreatic cancer: potential effects on clinical outcomes. ] Surg Oncol, 2007, 95(4): 332-336.
  • 2Raimondi S, Maisonneuve P, Lowenfels AB. Epidemiology of panc- reatic cancer: an overview. Nat Rev Gastroenterol Hepatol, 2009, 6(12): 699-670.
  • 3Khan SA, Toledano MB, Taylor-Robinson SD. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford), 2008, 10(2): 77-82.
  • 4蒋奶贵,许丽艳,郭明洲,李恩民.肿瘤相关蛋白NGAL的生物学特征[J].胃肠病学和肝病学杂志,2010,19(4):297-301. 被引量:14
  • 5Kjeldsen L, Johnsen AH, Sengelov H, et al. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem, 1993, 268(14): 10425-10432.
  • 6Friedl A, Stoesz SP, Buckley P, et al. Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression. Histochern ], 1999.31(7): 433-441.
  • 7Kjeldsen L, Cowland JB, Borregaard N. Human neutrophil gelatinase- associated lipocalin and homologous proteins in rat and mouse. Biochim BiophysActa, 2000, 1482(1-2): 272-283.
  • 8Chu ST, Lin H], Huang HL, et al. The hydrophobic pocket of 24p3 protein from mouse uterine luminal fluid: fatty acid and retinol binding activity and predicted structural similarity to lipocalins. J Pept Res, 1998, 52(5): 390-397.
  • 9Bratt T. Lipocalins and cancer. Biochim Biophys Acta, 2000, 1482 (1-2): 318-326.
  • 10Chakraborty S, Kaur S, Guha S, et al. The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochim Biophys Acta, 2012,1826(1): 129-169.

二级参考文献44

  • 1许丽艳,李恩民,牛永东,蔡唯佳,袁华敏,常静霞,沈忠英,曾毅.食管癌细胞NGAL基因-152~-60区段存在TPA反应元件[J].生物化学与生物物理进展,2006,33(2):140-148. 被引量:3
  • 2孟令新,李强,郭仁德,张毓青.裸鼠胰腺癌动物模型及其应用进展[J].中华实验外科杂志,2006,23(12):1583-1584. 被引量:18
  • 3Flo TH, Smith KD, Sato S, et al. Lipoealin 2 mediates an innate immune response to bacterial infection by sequestrating iron [ J]. Nature, 2004, 432(7019) : 917-921.
  • 4Berger T, Togawa A, Duncan GS, et al. Lipocalin 2-deficient mice exhibil increased sensitivity to E. coli infection but not to ischemia reperfusion injury [J]. Proc Natl Acad Sci U S A, 2006, 103(6) : 1834- 1839.
  • 5Yndestad A, Landro L, Ueland T, et al. Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure [ J]. Eur Heart J, 2009, 30 (10) : 1229-1236.
  • 6Kuwabara T, Mori K, Mukoyama M, et al. Urinary neutrophil gelatinase-associated.lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons [J]. Kidney Int, 2009, 75(3): 285- 294.
  • 7Bolignano D, Donato V, Lacquaniti A, et al. Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene [J]. Cancer Lett, 2010, 288(1): 10-16.
  • 8Bauer M, Eickhoff JC, Gould MN, et al. Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer [ J]. Breast Cancer Res Treat, 2008, 108 (3) : 389-397.
  • 9Zhang H, Xu L, Xiao D, et al. Upregulation of neutrophil gelatinaaeassociated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion [ J]. J Clin Pathol, 2007, 60(5): 555-561.
  • 10Kubben FJ, Sier CF, Hawinkels LJ, et al. Clinical evidence for aprotective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer [ J]. Eur J Cancer, 2007, 43 (12) : 1869- 1876.

共引文献15

同被引文献26

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部